NCT06732674View on ClinicalTrials.gov

Home Based Clinical Management of Interstitial Lung Disease in Systemic Rheumatic Diseases

NARecruitingINTERVENTIONAL
Enrollment

218

Participants

Timeline

Start Date

December 16, 2024

Primary Completion Date

October 1, 2026

Study Completion Date

February 28, 2028

Conditions
Interstitial Lung Disease with Progressive Fibrotic Phenotype in Diseases Classified ElsewhereSystemic Sclerosis PulmonaryDermatomyositisRheumatoid ArthritisSjogren Syndrome with Lung InvolvementConnective Tissue Diseases
Interventions
DIAGNOSTIC_TEST

A home monitoring strategy with event driven management

Bi-weekly home monitoring with forced vital capacity (FVC), patient reported outcome measures (PROMs), at-home measures of blood oxygen levels (SpO2) during 1-minute-sit-to-stand test (1MSTS) and temperature with algorithm based risk evaluation of deterioration and infection and consecutive event driven management

Trial Locations (1)

0873

RECRUITING

Oslo University Hospital, Oslo

All Listed Sponsors
collaborator

Carol Davila University of Medicine and Pharmacy

OTHER

collaborator

University of Zurich

OTHER

lead

Oslo University Hospital

OTHER